Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Alice Long

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cellular & Molecular Immunology|March 16, 2010
Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapsePaul L Bollyky, Stephen P Evanko, Rebecca P Wu, et al.
Science Translational Medicine|January 12, 2022
Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityKatharina Lambert, Keagan G Moo, Azlann Arnett, et al.
JCI Insight|July 11, 2023
Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetesLaura M Jacobsen, Kirsten Diggins, Lori Blanchfield, et al.
Critical Care Medicine|October 1, 2021
Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical IllnessCarmen Mikacenic, Pavan Bhatraju, Cassianne Robinson-Cohen, et al.
The Journal of Clinical Investigation|December 10, 2019
Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progressionAlice E Wiedeman, Virginia S Muir, Mario G Rosasco, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsPaul L Bollyky, Rebecca P Wu, Ben A Falk, et al.
Science Translational Medicine|November 27, 2015
Type 1 diabetes immunotherapy using polyclonal regulatory T cellsJeffrey A Bluestone, Jane H Buckner, Mark Fitch, et al.
European Journal of Immunology|January 13, 2022
Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetesJennie H M Yang, Kirsten A Ward-Hartstonge, Daniel J Perry, et al.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
Diabetes|June 23, 2012
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell functionS Alice Long, Mary Rieck, Srinath Sanda, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cellular & Molecular Immunology|March 16, 2010
Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapsePaul L Bollyky, Stephen P Evanko, Rebecca P Wu, et al.
Science Translational Medicine|January 12, 2022
Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityKatharina Lambert, Keagan G Moo, Azlann Arnett, et al.
JCI Insight|July 11, 2023
Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetesLaura M Jacobsen, Kirsten Diggins, Lori Blanchfield, et al.
Critical Care Medicine|October 1, 2021
Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical IllnessCarmen Mikacenic, Pavan Bhatraju, Cassianne Robinson-Cohen, et al.
The Journal of Clinical Investigation|December 10, 2019
Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progressionAlice E Wiedeman, Virginia S Muir, Mario G Rosasco, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsPaul L Bollyky, Rebecca P Wu, Ben A Falk, et al.
Science Translational Medicine|November 27, 2015
Type 1 diabetes immunotherapy using polyclonal regulatory T cellsJeffrey A Bluestone, Jane H Buckner, Mark Fitch, et al.
European Journal of Immunology|January 13, 2022
Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetesJennie H M Yang, Kirsten A Ward-Hartstonge, Daniel J Perry, et al.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
Diabetes|June 23, 2012
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell functionS Alice Long, Mary Rieck, Srinath Sanda, et al.
Pageof 8